The BioMedical group of VRV S.p.A has appointed Steven T. Shaw as its new President.
Shaw has been serving as President of the BioMedical group at Chart Industries Inc. for the past 15 years and will bring a wealth of experience to the Italian outfit.
Under his new role, Shaw (left) will be responsible for building upon the company’s current product platform by offering specifically-tailored products to regulatory and application requirements of breakout global markets such as cell therapy and biobanking.
... to continue reading you must be subscribed
